CHANTIBODY Trademark

Trademark Overview


On Friday, August 11, 2023, a trademark application was filed for CHANTIBODY with the United States Patent and Trademark Office. The USPTO has given the CHANTIBODY trademark a serial number of 98128436. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, August 13, 2024. This trademark is owned by Chantibody Therapeutics Inc.. The CHANTIBODY trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of cancer, immunological-inflammatory and other chronic conditions; Biological products, namely, a drug delivery system comprising antibodies or antibody fragments which extend the effect of a wide variety of therapeutic agents, for medical use and for use in medical treatment; Diagnostic preparations for medical purposes; Vaccines for human use; Therapeutic vaccines; Medical preparations, namely, antibodies and antibody fragments, for treatment of inflammatory diseases, neoplastic diseases, autoimmune diseases, and cancer; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical preparations for the treatment and/or prophylaxis of chronic disease
chantibody

General Information


Serial Number98128436
Word MarkCHANTIBODY
Filing DateFriday, August 11, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements


Description of MarkThe mark consists of the literal element "CHANTIBODY" in stylized font along with a radial three-loop design element in the upper right corner.
Goods and ServicesBiological preparations for the treatment of cancer, immunological-inflammatory and other chronic conditions; Biological products, namely, a drug delivery system comprising antibodies or antibody fragments which extend the effect of a wide variety of therapeutic agents, for medical use and for use in medical treatment; Diagnostic preparations for medical purposes; Vaccines for human use; Therapeutic vaccines; Medical preparations, namely, antibodies and antibody fragments, for treatment of inflammatory diseases, neoplastic diseases, autoimmune diseases, and cancer; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical preparations for the treatment and/or prophylaxis of chronic disease
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "CHANTIBODY" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChantibody Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCalifornia, CA 940251432

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2023NEW APPLICATION ENTERED
Monday, September 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2024ASSIGNED TO EXAMINER
Wednesday, June 5, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 12, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 5, 2024NON-FINAL ACTION E-MAILED